Clinical trial
Assessment of Ovarian Reserve in Patients With Fragile X Premutation
NCT07039734 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Ovarian Reserve in Patients With Fragile X Premutation
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 4, 2025
- Completion date
- January 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fmr1 gene premutation